Brief: Bellus Health and the NEOMED Institute announce agreement for development of treatment for chronic cough

BELLUS Health

28/02/2017 15:52

Feb 28 (Reuters) - Bellus Health Inc  BLU.TO  
    * Bellus Health and the NEOMED Institute announce an 
exclusive worldwide license agreement for the development of a 
treatment for chronic cough 
    * Under terms of agreement, Bellus Health will pay neomed an 
upfront fee of cad $3.2 million 
    * Upfront fee consists of CAD $1.7 million in cash and CAD 
$1.5 million with 5.8 million bellus health common shares 
    * As per agreement, NEOMED will be entitled to receive a 
royalty on net sales-based revenues 
 
Source text for Eikon:  ID:nCNW93VmYa  
Further company coverage:  BLU.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))